title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,INNMF,0.02074,Neutral,-0.020974
"Proactive news headlines including PVW Resources, Emperor Energy, GTI Resources and Meeka Gold",20220406T060704,https://www.benzinga.com/pressreleases/22/04/g26492263/proactive-news-headlines-including-pvw-resources-emperor-energy-gti-resources-and-meeka-gold,INNMF,0.04085,Neutral,0.005814
"Proactive news headlines including Amplia Therapeutics, American Rare Earths, Venture Minerals and Dundas Minerals",20220802T055929,https://www.benzinga.com/pressreleases/22/08/g28303664/proactive-news-headlines-including-amplia-therapeutics-american-rare-earths-venture-minerals-and-d,INNMF,0.043979,Neutral,-0.016995
"Proactive news headlines including Paradigm Biopharmaceuticals, Jindalee Resources, Incannex Healthcare and Amplia Therapeutics",20220317T065518,https://www.benzinga.com/pressreleases/22/03/g26177545/proactive-news-headlines-including-paradigm-biopharmaceuticals-jindalee-resources-incannex-healthc,INNMF,0.030567,Neutral,0.073278
